Prognosys Biosciences Inc - 92121 San Diego, CA

Business Name: Prognosys Biosciences Inc
Categorized In: Commercial Biotechnical Research
Address: 11125 Flintkote Avenue # A, San Diego, CA 92121
Phone Number: (858) 459-2428
Contact Person: Mark S Chee
Website Address: prognosysbio.com
NAICS Code: 541711
SIC Code: 8731
Business Type: B2B (Business to Business)
Founding Year: 2005
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $100.000 to $499.999
Share This Business:
Similar Businesses: Genestitute - San Diego, CA 92121
Abwiz Bio Inc - San Diego, CA 92121
Abide Therapeutics - San Diego, CA 92121
Miltenyi Biotec Inc - San Diego, CA 92121
Ignyta - San Diego, CA 92121
Center For Aquaculture Tech - San Diego, CA 92121
Aires Pharmaceuticals Inc - San Diego, CA 92121
Oranox - San Diego, CA 92121
Rd Biosciences Inc - San Diego, CA 92121
Zenobia Therapeutics - San Diego, CA 92121
Advantar Laboratories Inc - San Diego, CA 92121
Bps Bioscience - San Diego, CA 92121
Proacta Inc - San Diego, CA 92121
Anaptysbio Inc - San Diego, CA 92121
Nod Pharmaceuticals Inc - San Diego, CA 92121
Kinome Scan - San Diego, CA 92121
Dermatrends Inc - San Diego, CA 92121
One World Lab Inc - San Diego, CA 92121
Motivatrx LLC - San Diego, CA 92121
Mapp Biopharmaceutical Inc - San Diego, CA 92121

Prognosys Biosciences Inc provides professional Commercial Biotechnical Research from its single location at the coordinates 32.905622,-117.232219.

The company offers B2B variables under the SIC code 8731 and NAICS code 541711, while making an annual revenue of $100.000 to $499.999 and hiring a total of 1 to 4 employees.

Founded in 2005, the company can now be visited at 11125 Flintkote Avenue # A, San Diego, California 92121 or contacted through representative Mark S Chee at (858) 459-2428.

For frequently asked questions and further inquiries about professional Commercial Biotechnical Research, get to know more about Prognosys Biosciences Inc through its company website at prognosysbio.com. Engage with this business on its social media platforms through on Twitter and on Facebook.